Marqeta (MQ) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Marqeta (MQ) reported revenue of $150.39 million, up 20.1% over the same period last year. EPS came in at $0, compared to $0.23 in the year-ago quarter.The reported revenue represents a surprise of +7.38% over the Zacks Consensus Estimate of $140.05 million. With the consensus EPS estimate being -$0.03, the EPS surprise was +100%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Marqeta performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total Processing Volume (TPV): $91.39 billion versus the two-analyst average estimate of $89.84 billion.Revenues- Total platform services, net: $143.14 million versus the two-analyst average estimate of $132.31 million. The reported number represents a year-over-year change of +20%.Revenues- Other services: $7.26 million compared to the $7.85 million average estimate based on two analysts. The reported number represents a change of +21% year over year.View all Key Company Metrics for Marqeta here>>>Shares of Marqeta have returned -5.6% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Marqeta, Inc. (MQ): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks